Biotech AI Startup Unlearn Adds US$15 Million And OpenAI CTO To Board
By Krystal Hu
Unlearn.AI, which has built a machine learning platform that creates “digital twin” profiles of patients in clinical trials, has raised US$15 million to expand partnerships and accelerate regulatory approval, the company told Reuters on Tuesday.
The investment from Radical Ventures and Wittington Ventures valued the startup at $265 million, the company said.
Chief technology officer at Microsoft-backed OpenAI, Mira Murati is joining the startup’s board.
